You just read:

Aprea Therapeutics Announces First Patients Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Esophageal Cancer

News provided by

Aprea Therapeutics AB

Oct 16, 2017, 09:00 ET